Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/KAZIA-THERAPEUTICS-LIMITE-45081120/news/Kazia-Therapeutics-licenses-paxalisib-to-Sovargen-for-intractable-seizures-in-rare-central-nervous-s-46252986/?utm_source=whatsapp&utm_medium=social&utm_campaign=share